1Z3N | Oxidoreductase | date | Mar 14, 2005 |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
title | Human Aldose Reductase In Complex With Nadp+ And The Inhibit Lidorestat At 1.04 Angstrom | ||||||||||||||
authors | M.C.Van Zandt, M.L.Jones, D.E.Gunn, L.S.Geraci, J.H.Jones, D.R.Sa J.Sredy, J.L.Jacot, A.T.Dicioccio, T.Petrova, A.Mitschler, A.D.P | ||||||||||||||
compound | source | ||||||||||||||
Molecule: Aldose Reductase Chain: A Ec: 1.1.1.21 Engineered: Yes |
Organism_scientific: Homo Sapiens Organism_common: Human Organism_taxid: 9606 Expression_system: Escherichia Coli Bl21(De3) Expression_system_taxid: 469008 Expression_system_strain: Bl21de3 Expression_system_vector_type: Plasmid Expression_system_plasmid: Pet15b | ||||||||||||||
symmetry | Space Group: P 1 21 1 |
| |||||||||||||
crystal cell |
| ||||||||||||||
method | X-Ray Diffraction | resolution | 1.04 Å | ||||||||||||
ligand | 3NA, NDP BindingDB | enzyme | Oxidoreductase E.C.1.1.1.21 BRENDA | ||||||||||||
Gene Ontology |
| ||||||||||||||
Primary reference | Discovery of 3-[(4,5,7-trifluorobenzothiazol-2-yl)methyl]indole-N-acetic acid (lidorestat) and congeners as highly potent and selective inhibitors of aldose reductase for treatment of chronic diabetic complications., Van Zandt MC, Jones ML, Gunn DE, Geraci LS, Jones JH, Sawicki DR, Sredy J, Jacot JL, Dicioccio AT, Petrova T, Mitschler A, Podjarny AD, J Med Chem. 2005 May 5;48(9):3141-52. PMID:15857120 |
Data retrieval |
View 1Z3N in 3D |
Visual 3D analysis of 1Z3N |
Structure-derived information |
Sequence-derived information |
Other resources with information on 1Z3N |
Movements, Movies and Images |
OCA© by Jaime Prilusky, 1996-2014,2022 Bioinformatics Unit Weizmann Institute of Science |